genedx.com (WGS) Company Revenue

genedx.com - graphic logo of issuer WGS

Scaling test volumes through laboratory automation reduces costs, as confirmed by the current GURU.Markets platform chart for GeneDx Holdings Corp. (WGS). The company's product implementation dynamics are based on a leadership strategy in AI-powered exome sequencing. High-precision tests for neonatologists and geneticists generate revenue. The value of 0.46 shows the latest measure of the business's commercial strength, capturing the daily rate of revenue inflow.

GeneDx Holdings Corp. - WGS Revenue and Sales Volume (period 04/28/2023 - 11/18/2026)

Comprehensive metric breakdowns and analytics for GeneDx Holdings (WGS)

- market price and analyst price targets:
Comprehensive company analysis:GeneDx Holdings Corp.
Product sample of GeneDx

Ignoring the dynamics of trading revenue creates a risk of underestimating cyclical downturns, making daily sales volume calculations critical for capturing real shifts in demand. By analyzing the historical sales levels of GeneDx Holdings Corp. (WGS), an investor assesses the monetization of the company's unique exome database, where inelastic demand for high-precision diagnostics of rare diseases confirms the issuer's pricing power and the resilience of its fundamental indicators.

Competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Sales Revenue RARE (ultragenyx.com)|BEAM: Revenue and Sales Volume|Sarepta - Company Sales Revenue|TWST (twistbioscience.com) - Revenue and Sales Volume|Company Sales Volume TXG (10x Genomics Corp)|Revenue and Sales Volume NTLA|Revenue and Sales Volume Stoke Therapeutics, Inc. (STOK)|Company Revenue BioLife BLFS|WVE - Company Sales|Maze Therapeutics Corp - Revenue and Sales Volume|Sionna Pharma - Company Total Sales|Prime Medicine (PRME) - Company Revenue|tayshagtx.com (TSHA) - Revenue and Sales Volume|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales